ARTICLE | Company News
Valeant Pharmaceuticals, PreCision Dermatology deal
July 21, 2014 7:00 AM UTC
Valeant completed its acquisition of dermatology company PreCision for $475 million in cash, plus up to an additional $25 million in sales-based milestones (see BioCentury, Feb. 10). ...